These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3276632)

  • 1. P53 expression in breast cancer.
    Cattoretti G; Rilke F; Andreola S; D'Amato L; Delia D
    Int J Cancer; 1988 Feb; 41(2):178-83. PubMed ID: 3276632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas.
    Cattoretti G; Andreola S; Clemente C; D'Amato L; Rilke F
    Br J Cancer; 1988 Apr; 57(4):353-7. PubMed ID: 3291921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.
    Railo M; Lundin J; Haglund C; von Smitten K; von Boguslawsky K; Nordling S
    Acta Oncol; 1997; 36(4):369-74. PubMed ID: 9247096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between epidermal growth factor receptor (EGF-R) and other predictors of prognosis in breast carcinomas. An immunohistochemical study.
    Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
    Pathologica; 1993; 85(1100):637-44. PubMed ID: 8170712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?
    Wang X; Stolla M; Ring BZ; Yang Q; Laughlin TS; Rothberg PG; Skinner K; Hicks DG
    Hum Pathol; 2016 Sep; 55():196-201. PubMed ID: 27246177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.
    Gonidi M; Athanassiadou AM; Patsouris E; Tsipis A; Dimopoulos S; Kyriakidou V; Chelidonis G; Athanassiadou P
    Pathol Res Pract; 2011 Jun; 207(6):377-82. PubMed ID: 21621926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
    Järvinen TA; Holli K; Kuukasjärvi T; Isola JJ
    Br J Cancer; 1998 Jun; 77(12):2267-73. PubMed ID: 9649144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomorphological features of "minimal" carcinomas selected from a series of 2077 breast cancer cases].
    Martinazzi M; Mauri FM; Calandra C; Hotz AM; Crivelli F
    Pathologica; 2000 Apr; 92(2):65-71. PubMed ID: 10838870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the 85-kd membrane protein in primary human breast cancer: relationship to hormone receptor levels, DNA ploidy, and tumor grade.
    de la Torre M; Nygren P; Larsson R; Lindgren A; Tsuruo T; Bergh J
    Hum Pathol; 1995 Feb; 26(2):180-5. PubMed ID: 7532148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA aneuploidy in relation to the combination of analysis of estrogen receptor, progesterone receptor, p53 protein and epidermal growth factor receptor in 498 breast cancers.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    Oncology; 2002; 63(1):48-55. PubMed ID: 12187071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified immuno-enzymetric assay of the epidermal growth factor receptor in breast tumors: evaluation in 282 cases.
    Grimaux M; Mady E; Remvikos Y; Laine-Bidron C; Magdelenat H
    Int J Cancer; 1990 Feb; 45(2):255-62. PubMed ID: 2406203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival.
    Barbareschi M; Caffo O; Doglioni C; Fina P; Marchetti A; Buttitta F; Leek R; Morelli L; Leonardi E; Bevilacqua G; Dalla Palma P; Harris AL
    Br J Cancer; 1996 Jul; 74(2):208-15. PubMed ID: 8688323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
    Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
    Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
    Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
    Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.